BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 17526477)

  • 1. Modulation of prostaglandin activity, part 1: prostaglandin inhibition in the management of nonrheumatologic diseases: immunologic and hematologic aspects.
    Al-Waili NS; Saloom KY; Al-Waili T; Al-Waili A; Al-Waili H
    Adv Ther; 2007; 24(1):189-222. PubMed ID: 17526477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A potential concept in the management of tumors with modulation of prostaglandin, nitric oxide and antioxidants.
    Al-Waili NS
    ScientificWorldJournal; 2007 Mar; 7():466-78. PubMed ID: 17450309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-inflammatory drugs in the 21st century.
    Rainsford KD
    Subcell Biochem; 2007; 42():3-27. PubMed ID: 17612044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostaglandins, their inhibitors and cancer.
    Lupulescu A
    Prostaglandins Leukot Essent Fatty Acids; 1996 Feb; 54(2):83-94. PubMed ID: 8848435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostaglandins and chronic inflammation.
    Aoki T; Narumiya S
    Trends Pharmacol Sci; 2012 Jun; 33(6):304-11. PubMed ID: 22464140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostaglandins in pathogenesis and treatment of multiple sclerosis.
    Mirshafiey A; Jadidi-Niaragh F
    Immunopharmacol Immunotoxicol; 2010 Dec; 32(4):543-54. PubMed ID: 20233088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Combined Blockade of β-Adrenoceptor and COX-2 During the Perioperative Period to Improve Long-term Cancer Outcomes.
    Ricon I; Hiller JG; Ben-Eliyahu S
    Int Anesthesiol Clin; 2016; 54(4):72-91. PubMed ID: 27623131
    [No Abstract]   [Full Text] [Related]  

  • 8. Modulation of prostaglandin biosynthesis by nitric oxide and nitric oxide donors.
    Mollace V; Muscoli C; Masini E; Cuzzocrea S; Salvemini D
    Pharmacol Rev; 2005 Jun; 57(2):217-52. PubMed ID: 15914468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostaglandins and heart disease.
    Beamish RE; Das PK; Karmazyn M; Dhalla NS
    Can J Cardiol; 1985 Jan; 1(1):66-74. PubMed ID: 3850765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [New nonsteroidal anti-inflammatory agents: nitric oxide donors and selective cyclooxygenase-2 inhibitors].
    Bannwarth B; Berenbaum F
    Rev Med Interne; 1999 Aug; 20 Suppl 3():341s-345s. PubMed ID: 10480184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Yin-yang: balancing act of prostaglandins with opposing functions to regulate inflammation.
    Mandal AK; Zhang Z; Kim SJ; Tsai PC; Mukherjee AB
    J Immunol; 2005 Nov; 175(10):6271-3. PubMed ID: 16272277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostaglandins.
    Samuelsson B; Granström E; Green K; Hamberg M; Hammarström S
    Annu Rev Biochem; 1975; 44():669-95. PubMed ID: 806254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostaglandins and steroidogenesis in isolated bovine adrenal cells. Effects of ACTH, prostaglandin-synthesis inhibitors, prostaglandins and prostaglandin analogs.
    Rolland PH; Rolland AM; Benkoel L; Toga M
    Mol Cell Endocrinol; 1981 May; 22(2):179-93. PubMed ID: 6263734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostaglandins and cancer.
    Smith BJ; Wills MR; Savory J
    Ann Clin Lab Sci; 1983; 13(5):359-65. PubMed ID: 6357045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostaglandin inhibition and cardiovascular risk: maybe timing really is everything.
    Bertagnolli MM; Zauber AG; Solomon S
    Cancer Prev Res (Phila); 2009 Mar; 2(3):195-6. PubMed ID: 19258547
    [No Abstract]   [Full Text] [Related]  

  • 16. Role of cyclooxygenase-2 in bone resorption.
    Okada Y; Pilbeam C; Raisz L; Tanaka Y
    J UOEH; 2003 Jun; 25(2):185-95. PubMed ID: 12813861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nociceptors in cardiovascular functions: complex interplay as a result of cyclooxygenase inhibition.
    Premkumar LS; Raisinghani M
    Mol Pain; 2006 Aug; 2():26. PubMed ID: 16916451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adverse effects of COX-2 inhibitors.
    Sharma JN; Jawad NM
    ScientificWorldJournal; 2005 Aug; 5():629-45. PubMed ID: 16113940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of systemic inhibition of prostaglandin synthesis on muscle protein balance after trauma in the rat.
    Fisher BD; Baracos VE; Reid DC
    Can J Physiol Pharmacol; 1991 Jun; 69(6):831-6. PubMed ID: 1913329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated expression of cyclooxygenase-2 contributes to immune dysfunction in a murine model of trauma.
    Mackrell PJ; Daly JM; Mestre JR; Stapleton PP; Howe LR; Subbaramaiah K; Dannenberg AJ
    Surgery; 2001 Nov; 130(5):826-33. PubMed ID: 11685192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.